BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 27774883)

  • 1. Novel Aspects in the Pathogenesis of Nonalcoholic Steatohepatitis.
    Gentilini A; Caligiuri A; Provenzano A; Marra F
    Curr Mol Med; 2016; 16(8):710-720. PubMed ID: 27774883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathophysiology of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis.
    Manne V; Handa P; Kowdley KV
    Clin Liver Dis; 2018 Feb; 22(1):23-37. PubMed ID: 29128059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apoptosis and non-alcoholic fatty liver diseases.
    Kanda T; Matsuoka S; Yamazaki M; Shibata T; Nirei K; Takahashi H; Kaneko T; Fujisawa M; Higuchi T; Nakamura H; Matsumoto N; Yamagami H; Ogawa M; Imazu H; Kuroda K; Moriyama M
    World J Gastroenterol; 2018 Jul; 24(25):2661-2672. PubMed ID: 29991872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonalcoholic Fatty Liver Disease: Basic Pathogenetic Mechanisms in the Progression From NAFLD to NASH.
    Pierantonelli I; Svegliati-Baroni G
    Transplantation; 2019 Jan; 103(1):e1-e13. PubMed ID: 30300287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonalcoholic Steatohepatitis.
    Suzuki A; Diehl AM
    Annu Rev Med; 2017 Jan; 68():85-98. PubMed ID: 27732787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent Insights into the Pathogenesis of Nonalcoholic Fatty Liver Disease.
    Arab JP; Arrese M; Trauner M
    Annu Rev Pathol; 2018 Jan; 13():321-350. PubMed ID: 29414249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endoplasmic reticulum stress related molecular mechanisms in nonalcoholic steatohepatitis.
    Bozaykut P; Sahin A; Karademir B; Ozer NK
    Mech Ageing Dev; 2016 Jul; 157():17-29. PubMed ID: 27393639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevation of liver endoplasmic reticulum stress in a modified choline-deficient l-amino acid-defined diet-fed non-alcoholic steatohepatitis mouse model.
    Muraki Y; Makita Y; Yamasaki M; Amano Y; Matsuo T
    Biochem Biophys Res Commun; 2017 May; 486(3):632-638. PubMed ID: 28322783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis of Nonalcoholic Steatohepatitis.
    Machado MV; Diehl AM
    Gastroenterology; 2016 Jun; 150(8):1769-77. PubMed ID: 26928243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intestinally derived bacterial products stimulate development of nonalcoholic steatohepatitis.
    Dornas W; Lagente V
    Pharmacol Res; 2019 Mar; 141():418-428. PubMed ID: 30658094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenesis of Nonalcoholic Steatohepatitis: Interactions between Liver Parenchymal and Nonparenchymal Cells.
    Magee N; Zou A; Zhang Y
    Biomed Res Int; 2016; 2016():5170402. PubMed ID: 27822476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonalcoholic fatty liver disease: diagnosis, pathogenesis, and management.
    Başaranoğlu M; Örmeci N
    Turk J Gastroenterol; 2014 Apr; 25(2):127-32. PubMed ID: 25003670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p16 deficiency promotes nonalcoholic steatohepatitis via regulation of hepatic oxidative stress.
    Lv F; Wu J; Miao D; An W; Wang Y
    Biochem Biophys Res Commun; 2017 Apr; 486(2):264-269. PubMed ID: 28286271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular pathways of nonalcoholic fatty liver disease development and progression.
    Bessone F; Razori MV; Roma MG
    Cell Mol Life Sci; 2019 Jan; 76(1):99-128. PubMed ID: 30343320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipidomic biomarkers and mechanisms of lipotoxicity in non-alcoholic fatty liver disease.
    Svegliati-Baroni G; Pierantonelli I; Torquato P; Marinelli R; Ferreri C; Chatgilialoglu C; Bartolini D; Galli F
    Free Radic Biol Med; 2019 Nov; 144():293-309. PubMed ID: 31152791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-Alcoholic Fatty Liver Disease.
    Engin A
    Adv Exp Med Biol; 2017; 960():443-467. PubMed ID: 28585211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utilization of animal models to investigate nonalcoholic steatohepatitis-associated hepatocellular carcinoma.
    Wu J
    Oncotarget; 2016 Jul; 7(27):42762-42776. PubMed ID: 27072576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-alcoholic steatohepatitis: pathogenesis and novel therapeutic approaches.
    Schuppan D; Schattenberg JM
    J Gastroenterol Hepatol; 2013 Aug; 28 Suppl 1():68-76. PubMed ID: 23855299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Will Studies in Nonalcoholic Steatohepatitis Help Manage Alcoholic Steatohepatitis?
    Sundaram V; Morgan TR
    Clin Liver Dis; 2019 Feb; 23(1):157-165. PubMed ID: 30454829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-alcoholic steatohepatitis pathogenesis: sublethal hepatocyte injury as a driver of liver inflammation.
    Ibrahim SH; Hirsova P; Gores GJ
    Gut; 2018 May; 67(5):963-972. PubMed ID: 29367207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.